{"id":235738,"date":"2026-09-08T17:38:36","date_gmt":"2026-09-08T12:08:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=235738"},"modified":"2026-09-08T17:38:36","modified_gmt":"2026-09-08T12:08:36","slug":"alkem-laboratories-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"Alkem Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Alkem Laboratories share price Rs 5,181.00 on 8 September 2026, down 1.17%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 521.49 crore. Q2 FY26 base a profit of Rs 779.60 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Alkem Laboratories Q2 results date for FY27 is not confirmed, and Alkem Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 4,104.68 crore in revenue and a profit of Rs 779.60 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n<p>The Alkem Laboratories Q2 results FY27 announcement is the next scheduled earnings event for <a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd.<\/a>, a pharmaceutical company with a large Indian branded generics business in anti-infectives and gastro-intestinal therapies, plus a United States generics operation. The stock traded at Rs 5,181.00 on the NSE on 8 September 2026, down 1.17% from the previous close of Rs 5,242.50, about 12.7% below its 52-week high of Rs 5,933.50 and 2.1% above its 52-week low of Rs 5,075.00.<\/p>\n<p>What makes the Alkem Laboratories Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 4,104.68 crore of revenue and a profit of Rs 779.60 crore, while the most recent quarter on record, Q1 FY27, produced Rs 3,892.90 crore and a profit of Rs 521.49 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=alkem_q2_fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#When_Is_the_Alkem_Laboratories_Q2_Results_FY27_Date\" title=\"When Is the Alkem Laboratories Q2 Results FY27 Date?\">When Is the Alkem Laboratories Q2 Results FY27 Date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Alkem_Laboratories_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\" title=\"Alkem Laboratories Q2 Results Expectations: What the Market Is Actually Tracking\">Alkem Laboratories Q2 Results Expectations: What the Market Is Actually Tracking<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Alkem_Laboratories_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\" title=\"Alkem Laboratories Q2 Results Preview: The Q1 FY27 Actuals It Builds On\">Alkem Laboratories Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Q2_FY26_Base_The_Comparison_Alkem_Laboratories_Q2_Results_FY27_Must_Beat\" title=\"Q2 FY26 Base: The Comparison Alkem Laboratories Q2 Results FY27 Must Beat\">Q2 FY26 Base: The Comparison Alkem Laboratories Q2 Results FY27 Must Beat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Alkem_Laboratories_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\" title=\"Alkem Laboratories Quarterly Results Trend Over the Last Four Quarters\">Alkem Laboratories Quarterly Results Trend Over the Last Four Quarters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Key_Factors_That_Could_Shape_Alkem_Laboratories_Q2_Results_FY27\" title=\"Key Factors That Could Shape Alkem Laboratories Q2 Results FY27\">Key Factors That Could Shape Alkem Laboratories Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Acute_Therapy_Seasonality\" title=\"Acute Therapy Seasonality\">Acute Therapy Seasonality<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#United_States_Generics_Pricing\" title=\"United States Generics Pricing\">United States Generics Pricing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Share_Price_at_the_Bottom_of_Its_Range\" title=\"Share Price at the Bottom of Its Range\">Share Price at the Bottom of Its Range<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Alkem_Laboratories_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\" title=\"Alkem Laboratories Q2 Results FY27: Share Price and Valuation Going Into the Print\">Alkem Laboratories Q2 Results FY27: Share Price and Valuation Going Into the Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_Investors_Should_Watch_When_Alkem_Laboratories_Q2_Results_Are_Announced\" title=\"What Investors Should Watch When Alkem Laboratories Q2 Results Are Announced\">What Investors Should Watch When Alkem Laboratories Q2 Results Are Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Conclusion_on_Alkem_Laboratories_Q2_Results_FY27\" title=\"Conclusion on Alkem Laboratories Q2 Results FY27\">Conclusion on Alkem Laboratories Q2 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#FAQs_on_Alkem_Laboratories_Q2_Results_FY27\" title=\"FAQs on Alkem Laboratories Q2 Results FY27\">FAQs on Alkem Laboratories Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_is_the_Alkem_Laboratories_Q2_results_date_for_FY27\" title=\"What is the Alkem Laboratories Q2 results date for FY27?\">What is the Alkem Laboratories Q2 results date for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_quarter_do_the_Alkem_Laboratories_Q2_results_2026_cover\" title=\"What quarter do the Alkem Laboratories Q2 results 2026 cover?\">What quarter do the Alkem Laboratories Q2 results 2026 cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_were_the_Alkem_Laboratories_Q1_FY27_results\" title=\"What were the Alkem Laboratories Q1 FY27 results?\">What were the Alkem Laboratories Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_were_Alkem_Laboratories_Q2_FY26_results_in_the_September_2025_quarter\" title=\"What were Alkem Laboratories Q2 FY26 results in the September 2025 quarter?\">What were Alkem Laboratories Q2 FY26 results in the September 2025 quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_are_the_main_Alkem_Laboratories_Q2_results_expectations_this_quarter\" title=\"What are the main Alkem Laboratories Q2 results expectations this quarter?\">What are the main Alkem Laboratories Q2 results expectations this quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#What_is_Alkem_Laboratories_share_price_today_ahead_of_the_Q2_earnings\" title=\"What is Alkem Laboratories share price today ahead of the Q2 earnings?\">What is Alkem Laboratories share price today ahead of the Q2 earnings?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-preview-date-expectations\/#Is_Alkem_Laboratories_a_good_stock_to_buy_before_the_Q2_results\" title=\"Is Alkem Laboratories a good stock to buy before the Q2 results?\">Is Alkem Laboratories a good stock to buy before the Q2 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"When_Is_the_Alkem_Laboratories_Q2_Results_FY27_Date\"><\/span><strong>When Is the Alkem Laboratories Q2 Results FY27 Date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Alkem Laboratories Q2 results date for FY27 is not confirmed. As of 8 September 2026, Alkem Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.<\/p>\n<p>What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Alkem Laboratories Q2 results date becomes public through that filing rather than through any advance announcement.<\/p>\n<p>The Alkem Laboratories Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Alkem Laboratories.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\"><\/span><strong>Alkem Laboratories Q2 Results Expectations: What the Market Is Actually Tracking<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No verified analyst estimate for the Alkem Laboratories Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Alkem Laboratories. The Alkem Laboratories Q2 results watchlist below is built from what the company has actually reported and disclosed.<\/p>\n<p>The first is the September 2025 base, which is the strongest of the last five quarters at Rs 4,104.68 crore in revenue and Rs 779.60 crore in profit. The anti-infectives season peaks in that quarter, so it is a demanding comparison by construction.<\/p>\n<p>The second is the profit gap. Q1 FY27 delivered Rs 521.49 crore against Rs 668.32 crore a year earlier on higher revenue, with operating margin of 24.57% against 26.36%, so cost or mix has been working against the company.<\/p>\n<p>The third is the March 2026 quarter, when profit fell to Rs 251.68 crore at a 16.17% margin. That single weak quarter sits inside the trailing twelve months and drags the reported earnings multiple, so it should be understood before drawing conclusions.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Alkem Laboratories Ltd. Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\"><\/span><strong>Alkem Laboratories Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Ltd. reported revenue of Rs 3,892.90 crore in Q1 FY27, up 10.98% from Rs 3,507.63 crore in Q1 FY26, and a profit of Rs 521.49 crore at the net level, down 21.97% from Rs 668.32 crore in Q1 FY26. These are reported actuals, not estimates.<\/p>\n<p>Sequentially, revenue was up 2.35% over the March 2026 quarter figure of Rs 3,803.39 crore, and net profit was up 107.20% from Rs 251.68 crore in Q4 FY26. Operating margin stood at 24.57% in Q1 FY27 against 25.61% in the September 2025 quarter, which is the comparison the Alkem Laboratories Q2 results print will be read against.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Base_The_Comparison_Alkem_Laboratories_Q2_Results_FY27_Must_Beat\"><\/span><strong>Q2 FY26 Base: The Comparison Alkem Laboratories Q2 Results FY27 Must Beat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Ltd. reported revenue of Rs 4,104.68 crore and a profit of Rs 779.60 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Alkem Laboratories Q2 results preview.<\/p>\n<p>Net profit in that base quarter was above the Rs 521.49 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 4,104.68 crore sits above the Rs 3,892.90 crore of the June 2026 quarter, which frames how much sequential movement the Alkem Laboratories Q2 results print needs to show growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\"><\/span><strong>Alkem Laboratories Quarterly Results Trend Over the Last Four Quarters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>4,104.68<\/td>\n<td>779.60<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>3,879.92<\/td>\n<td>653.53<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>3,803.39<\/td>\n<td>251.68<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>3,892.90<\/td>\n<td>521.49<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company&#8217;s exchange filings, and they are the only basis this Alkem Laboratories Q2 results preview uses.<\/p>\n<p>Revenue across those four quarters ranged from Rs 3,803.39 crore to Rs 4,104.68 crore, and net profit from Rs 251.68 crore to Rs 779.60 crore. That spread is the honest context for the Alkem Laboratories Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_That_Could_Shape_Alkem_Laboratories_Q2_Results_FY27\"><\/span><strong>Key Factors That Could Shape Alkem Laboratories Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Alkem Laboratories Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Alkem Laboratories has already reported.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Acute_Therapy_Seasonality\"><\/span><strong>Acute Therapy Seasonality<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Alkem Laboratories is weighted towards anti-infectives and acute therapies, which sell hardest through the monsoon and post-monsoon months. That makes the September quarter structurally the biggest of the year for this company.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"United_States_Generics_Pricing\"><\/span><strong>United States Generics Pricing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The American business faces continuous price erosion in generics. Any new launch or approval offsets that, and the balance between the two is what management commentary usually addresses.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Share_Price_at_the_Bottom_of_Its_Range\"><\/span><strong>Share Price at the Bottom of Its Range<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at Rs 5,181.00, close to its 52-week low of Rs 5,075.00 and well below both its 50-day average of Rs 5,512.14 and its 200-day average of Rs 5,519.68, with a 14-day RSI of 29.03 in oversold territory.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\"><\/span><strong>Alkem Laboratories Q2 Results FY27: Share Price and Valuation Going Into the Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories share price today is Rs 5,181.00 on the NSE, down Rs 61.50 or 1.17% from the previous close of Rs 5,242.50 on 8 September 2026, ahead of the Alkem Laboratories Q2 results announcement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value (8 September 2026)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>ALKEM<\/td>\n<\/tr>\n<tr>\n<td>Current Market Price<\/td>\n<td>Rs 5,181.00<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 5,933.50<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 5,075.00<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Rs 61,935 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>28.10<\/td>\n<\/tr>\n<tr>\n<td>Sector PE<\/td>\n<td>37.70<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>4.48<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 184.35<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 1,155.87<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.15<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>16.66%<\/td>\n<\/tr>\n<tr>\n<td>50-Day Moving Average<\/td>\n<td>Rs 5,512.14<\/td>\n<\/tr>\n<tr>\n<td>200-Day Moving Average<\/td>\n<td>Rs 5,519.68<\/td>\n<\/tr>\n<tr>\n<td>RSI (14)<\/td>\n<td>29.03<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock trades below both its 50-day average of Rs 5,512.14 and its 200-day average of Rs 5,519.68, with a 14-day RSI of 29.03. None of this is a view on where the shares go once the Alkem Laboratories Q2 results are announced, and no price target is offered here.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Alkem Laboratories Ltd. live price and quarterly earnings updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_When_Alkem_Laboratories_Q2_Results_Are_Announced\"><\/span><strong>What Investors Should Watch When Alkem Laboratories Q2 Results Are Announced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four lines carry most of the information in a company of this size, and reading them in order keeps the Alkem Laboratories Q2 results print in proportion.<\/p>\n<ol>\n<li>Revenue against the Rs 4,104.68 crore reported in the September 2025 base quarter<\/li>\n<li>Net profit against a profit of Rs 779.60 crore in that same quarter<\/li>\n<li>Operating margin against 24.57% in Q1 FY27<\/li>\n<li>Any exceptional item, provision or one-off gain disclosed alongside the numbers<\/li>\n<\/ol>\n<p>A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Alkem Laboratories Q2 results announcement should be read together with the notes to the results rather than the headline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Alkem_Laboratories_Q2_Results_FY27\"><\/span><strong>Conclusion on Alkem Laboratories Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Alkem Laboratories Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Alkem Laboratories Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.<\/p>\n<p>On that basis the Alkem Laboratories Q2 results FY27 print faces a base of Rs 4,104.68 crore in revenue and a profit of Rs 779.60 crore, with the most recent quarter having delivered Rs 3,892.90 crore and a profit of Rs 521.49 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Alkem Laboratories, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Alkem_Laboratories_Q2_Results_FY27\"><\/span><strong>FAQs on Alkem Laboratories Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Alkem_Laboratories_Q2_results_date_for_FY27\"><\/span><strong>What is the Alkem Laboratories Q2 results date for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Alkem Laboratories Q2 results date for FY27 is not confirmed. Alkem Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_quarter_do_the_Alkem_Laboratories_Q2_results_2026_cover\"><\/span><strong>What quarter do the Alkem Laboratories Q2 results 2026 cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Alkem Laboratories Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Alkem Laboratories Ltd. reports revenue, operating profit and net profit for that period, and the Alkem Laboratories Q2 results filing also carries the notes to the accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_Alkem_Laboratories_Q1_FY27_results\"><\/span><strong>What were the Alkem Laboratories Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Ltd. reported revenue of Rs 3,892.90 crore in Q1 FY27 and a profit of Rs 521.49 crore at the net level. Revenue was up 10.98% versus Q1 FY26 and net profit was down 21.97% from Rs 668.32 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Alkem_Laboratories_Q2_FY26_results_in_the_September_2025_quarter\"><\/span><strong>What were Alkem Laboratories Q2 FY26 results in the September 2025 quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Ltd. reported revenue of Rs 4,104.68 crore and a profit of Rs 779.60 crore in Q2 FY26. Operating margin was 25.61%. Those figures form the base for the Alkem Laboratories Q2 results FY27 comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_Alkem_Laboratories_Q2_results_expectations_this_quarter\"><\/span><strong>What are the main Alkem Laboratories Q2 results expectations this quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No verified analyst estimate is publicly available. The Alkem Laboratories Q2 results expectations centre on revenue against the Rs 4,104.68 crore base, net profit against a profit of Rs 779.60 crore, operating margin against 24.57% in Q1 FY27, and any exceptional item disclosed with the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Alkem_Laboratories_share_price_today_ahead_of_the_Q2_earnings\"><\/span><strong>What is Alkem Laboratories share price today ahead of the Q2 earnings?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories share price is Rs 5,181.00 on the NSE as of 8 September 2026, down 1.17% from Rs 5,242.50. The stock is about 12.7% below its 52-week high of Rs 5,933.50 and 2.1% above its 52-week low of Rs 5,075.00, at a market capitalisation of Rs 61,935 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alkem_Laboratories_a_good_stock_to_buy_before_the_Q2_results\"><\/span><strong>Is Alkem Laboratories a good stock to buy before the Q2 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, sell or hold recommendation on Alkem Laboratories Ltd.. The stock trades at a price-to-book ratio of 4.48 with a return on equity of 16.66%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Alkem Laboratories Q2 results date for FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Alkem Laboratories Q2 results date for FY27 is not confirmed. Alkem Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.\"}},{\"@type\":\"Question\",\"name\":\"What quarter do the Alkem Laboratories Q2 results 2026 cover?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Alkem Laboratories Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Alkem Laboratories Ltd. reports revenue, operating profit and net profit for that period, and the Alkem Laboratories Q2 results filing also carries the notes to the accounts.\"}},{\"@type\":\"Question\",\"name\":\"What were the Alkem Laboratories Q1 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories Ltd. reported revenue of Rs 3,892.90 crore in Q1 FY27 and a profit of Rs 521.49 crore at the net level. Revenue was up 10.98% versus Q1 FY26 and net profit was down 21.97% from Rs 668.32 crore in Q1 FY26.\"}},{\"@type\":\"Question\",\"name\":\"What were Alkem Laboratories Q2 FY26 results in the September 2025 quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories Ltd. reported revenue of Rs 4,104.68 crore and a profit of Rs 779.60 crore in Q2 FY26. Operating margin was 25.61%. Those figures form the base for the Alkem Laboratories Q2 results FY27 comparison.\"}},{\"@type\":\"Question\",\"name\":\"What are the main Alkem Laboratories Q2 results expectations this quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No verified analyst estimate is publicly available. The Alkem Laboratories Q2 results expectations centre on revenue against the Rs 4,104.68 crore base, net profit against a profit of Rs 779.60 crore, operating margin against 24.57% in Q1 FY27, and any exceptional item disclosed with the numbers.\"}},{\"@type\":\"Question\",\"name\":\"What is Alkem Laboratories share price today ahead of the Q2 earnings?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories share price is Rs 5,181.00 on the NSE as of 8 September 2026, down 1.17% from Rs 5,242.50. The stock is about 12.7% below its 52-week high of Rs 5,933.50 and 2.1% above its 52-week low of Rs 5,075.00, at a market capitalisation of Rs 61,935 crore.\"}},{\"@type\":\"Question\",\"name\":\"Is Alkem Laboratories a good stock to buy before the Q2 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not offer a buy, sell or hold recommendation on Alkem Laboratories Ltd.. The stock trades at a price-to-book ratio of 4.48 with a return on equity of 16.66%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories Q2 results FY27 date is not yet confirmed by the exchanges. Here is the September 2026 quarter watchlist for Alkem Laboratories Ltd., built on actual Q1 FY27 and Q2 FY26 numbers with no invented estimates.<\/p>\n","protected":false},"author":29,"featured_media":235737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-235738","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["235737"],"rank_math_title":["Alkem Laboratories Q2 Results FY27: Date, Expectations"],"rank_math_description":["Alkem Laboratories Q2 results FY27 preview: results date status, key expectations, Q1 FY27 and Q2 FY26 actuals plus valuation before the September 2026 print."],"rank_math_focus_keyword":["Alkem Laboratories Q2 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/alkem-laboratories-q2-results-fy27-preview-date-expectations.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/235738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=235738"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/235738\/revisions"}],"predecessor-version":[{"id":235739,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/235738\/revisions\/235739"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/235737"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=235738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=235738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=235738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}